Your browser doesn't support javascript.
loading
Treatment with estradiol cypionate at progesterone withdrawal reduces handling without compromising the pregnancy rate to timed-AI in buffalo.
Tonizza de Carvalho, Nelcio Antonio; Soares de Carvalho, Júlia Gleyci; Sales, José Nélio de Sousa; Guerreiro, Bruna Martins; Freitas, Bruno Gonzalez de; D'Occhio, Michael J; Baruselli, Pietro Sampaio.
  • Tonizza de Carvalho NA; Research and Development Unit of Registro / Diversified Animal Science Research Center / Institute of Animal Science, Registro, São Paulo, Brazil. Electronic address: nelcio@iz.sp.gov.br.
  • Soares de Carvalho JG; Human Reproduction Section, Division of Urology, Department of Surgery, São Paulo Federal University, São Paulo, São Paulo, Brazil.
  • Sales JNS; Department of Animal Science, UFLA, Lavras, Minas Gerais, Brazil; Department of Veterinary Medicine, Federal University of Juiz de Fora, Juiz de Fora, Minas Gerais, Brazil.
  • Guerreiro BM; Ourofino Saúde Animal, Cravinhos, São Paulo, Brazil.
  • Freitas BG; Ourofino Saúde Animal, Cravinhos, São Paulo, Brazil.
  • D'Occhio MJ; School of Life and Environmental Sciences, Faculty of Science, The University of Sydney, New South Wales, Australia.
  • Baruselli PS; Department of Animal Reproduction, University of São Paulo, São Paulo, São Paulo, Brazil. Electronic address: barusell@usp.br.
Theriogenology ; 157: 498-502, 2020 Nov.
Article en En | MEDLINE | ID: mdl-32905899
ABSTRACT
The aim of this study was to determine if treatment with estradiol cypionate (EC) at the time of P4 withdrawal induced ovulation in a synchronization/timed-AI (TAI) protocol in buffalo. In Experiment 1, 56 buffaloes received an intravaginal P4 device (1.0 g) plus estradiol benzoate (EB, 2.0 mg im) on Day 0 (D0). On Day 9, the P4 device was removed and buffaloes were given PGF2α (0.53 mg im sodium cloprostenol) plus eCG (400 IU im). Buffaloes were then randomly allocated to one of two groups Group GEC (n = 29), treated with EC (1.0 mg im) at P4 device removal; Group GEB (n = 27), treated with EB (1.0 mg im) 24 h after P4 device removal. Ovarian ultrasound was undertaken on D0, to ascertain general ovarian status; D9 to D11 (every 24 h), to measure diameter of the largest follicle (LF) and follicular growth rate; D11 to D13 (every 12 h for 72 h), to determine the time of ovulation and ovulation rate. Following P4 device removal, Groups GEC and GEB had a similar follicular growth rate (0.9 ± 0.1 and 1.1 ± 0.1 mm/day, respectively; P = 0.15) and similar LF diameter on D11 (11.4 ± 0.6 and 12.5 ± 0.5 mm; P = 0.12). Groups GEC and GEB also had a similar diameter of the ovulatory follicle (13.0 ± 0.5 and 13.4 ± 0.6 mm; P = 0.52), interval from P4 device removal to ovulation (68.2 ± 2.8 and 71.1 ± 1.4 h; P = 0.41) and ovulation rate (62.1% and 70.4%; P = 0.44). In Experiment 2, 199 buffaloes were assigned to the two treatments in Experiment 1 (GEC, n = 100; GEB, n = 99). All animals underwent TAI 56 h after P4 device removal and pregnancy diagnosis was preformed on D41. The pregnancy rate was similar for Groups GEC and GEB (50.0 and 45.5%, respectively; P = 0.45). The findings indicate that treatment with EC at the time of P4 withdrawal induces ovulation and achieves the same pregnancy rate to TAI as treatment with EB 24 h after P4 removal. The use of EC requires one less handling which is highly important in facilitating practical adoption of TAI in assisted breeding and genetic improvement in buffalo.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Progesterona / Búfalos Tipo de estudio: Guideline Límite: Animals / Pregnancy Idioma: En Año: 2020 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Progesterona / Búfalos Tipo de estudio: Guideline Límite: Animals / Pregnancy Idioma: En Año: 2020 Tipo del documento: Article